Iovance Biotherapeutics Inc (IOVA)

NASDAQ HEALTHCARE

$4.11 +11.08% RSI 62 Neutral Add Alert

Moving Averages

SMA 200

$2.79

Price above

Company Profile

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.65B

P/E Ratio

None

EPS

$-0.92

Beta

0.688